Since kinds of literature had confirmed that p53 plays an irreplaceable role in the chemoresistance of breast carcinoma, our aforementioned results demonstrated that BCAS3 promoted p53 protein ubiquitination degradation; therefore, we speculated that chemoresistance conferred by BCAS3 may be mediated by p53. The gene discussed is TP53; the disease is breast carcinoma.